抗肿瘤药物临床研究论坛

返回主日程
9:00 - 12:00
  • 抗肿瘤药物临床研究论坛
  • Oncology Drugs Clinical Research Forum
9:00 - 10:15
  • 第一阶段
  • Session I
    • 主持人
  • 马军 ， 中国药促会抗肿瘤药物临床研究专业委员会副主任委员、哈尔滨血液病肿瘤研究所所长
  • MA Jun , Vice chairman of Anti-tumor Professional Committee of PhIRDA, Director of Harbin Institute of Hematology and Oncology
9:00 - 9:30
  • 主题报告1
  • Keynote Speech 1
  • 在科技创新活动中培养青年人才
  • Cultivating Youth Talent in Scientific Innovation Programs
  • 马骏 中国科学院院士、中山大学肿瘤防治中心常务副院长
  • MA Jun , Academician of the Chinese Academy of Sciences，Executive Vice-President of Sun Yat-sen University Cancer Center
9:30 - 9:55
  • 主题报告2
  • Keynote Speech 2
  • 髓系细胞与肿瘤免疫微环境塑造
  • Myeloid Cells and the Shaping of the Tumor Immune Microenvironment
  • 郑利民 中山大学教授、教育部“基因功能与调控重点实验室”主任
  • ZHENG Limin , Director of Key Laboratory of Gene Engineering of the Ministry of Education, Dean at School of Life Science, Sun Yat-sen University
9:55 - 11:10
  • 第二阶段
  • Session 2
    • 主持人
  • 薛俊丽 ， 中国药促会抗肿瘤药物临床研究专业委员会秘书长、同济大学附属东方医院肿瘤新药I期临床研究中心副主任
  • XUE Junli , Secretary General of Professional Committee for Clinical Research on Antitumor Drugs of PhIRDA ,Vice director of Phase I clinical trial center of East Hospital Affiliated to Tongji University
9:55 - 10:20
  • 主题报告3
  • Keynote Speech 3
  • 研究型医院如何助力生物医药产业创新发展
  • How Do Research Hospitals Promote the Innovation of Biopharmaceutical Industry
  • 冯晨 高博医疗集团副总裁、上海高博肿瘤医院执行院长
  • FENG Chen , Vice President of Gobroad Healthcare Group ,Executive President of Shanghai Gobroad Cancer Hospital
10:20 - 10:45
  • 主题报告4
  • Keynote Speech 4
  • 基因检测在肿瘤精准诊疗中的应用
  • The Application of Genetic Testing in Precision Oncology
  • 李子明 上海市胸科医院肿瘤科主任
  • LI Ziming , Department Director of Shanghai Chest Hospital
10:45 - 11:10
  • 主题报告5
  • Keynote Speech 5
  • 商业健康险全面升级赋能肿瘤医药产业
  • The Comprehensive Upgrading of Commercial Health Insurance Enables the Cancer Pharmaceutical Industry
  • 王润东 镁信健康高级总裁
  • WANG Rundong , Senior President of MgX Health Technology Co., Ltd
11:10 - 12:00
  • 主题讨论
  • Panel
  • 三医协同推动中国抗肿瘤药物水平提升
  • The Synergy of Medicine, Industry, and Research Driving the Advancement of Antitumor Drug Development in China
    • 主持人
  • 马军 ， 中国药促会抗肿瘤药物临床研究专业委员会副主任委员、哈尔滨血液病肿瘤研究所所长
  • MA Jun , Vice chairman of Anti-tumor Professional Committee of PhIRDA, Director of Harbin Institute of Hematology and Oncology
    • Panel嘉宾
  • 薛俊丽 ， 中国药促会抗肿瘤药物临床研究专业委员会秘书长、同济大学附属东方医院肿瘤新药I期临床研究中心副主任
  • XUE Junli , Secretary General of Professional Committee for Clinical Research on Antitumor Drugs of PhIRDA ,Vice director of Phase I clinical trial center of East Hospital Affiliated to Tongji University
  • 罗丹 ， 罗氏制药中国全国市场准入部副总裁
  • LUO Dan , National Market Access Vice President of Roche Pharmaceuticals China
  • 徐俊芳 ， 华东医药首席医学官
  • XU Junfang , Chief Medical Officer of Global Development Center of Huadong Medicine
  • 张勇 ， 醴泽资本创始管理合伙人
  • ZHANG Yong , LYZZ Capital, Co-Founder, Managing Partner